Denise R. Singleton
Denise R. Singleton's purchase track record
Denise R. Singleton has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/25/2026 | AMRZ | $154K | pending | pending | — |
| 8/8/2025 | AMRZ | $191K | +3.7% | +22.5% | +8.5% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Phillips 66 Raises Dividend, JV Rebrands Forecourts. Phillips 66 announced an increase in its quarterly dividend, highlighting its financial position. Meanwhile, Warrenton Oil, a joint venture associated with the company, rebranded 18 FastLane forecourts. Despite these corporate developments, the stock declined while the broader market posted gains. The company remains a key focus for dividend-focused market participants.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Teledyne FLIR Unveils New Counter-Drone Radar at AUSA 2026. Teledyne FLIR Defense introduced the Ranger R10-3DX, a compact mid-range counter-drone radar, during the AUSA 2026 event. This product launch highlights the company's ongoing focus on defense technology solutions. Additionally, Teledyne has announced details for its upcoming third-quarter 2026 earnings webcast, keeping investors informed on future financial reporting.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
IDEX price target raised to $285 by RBC Capital. RBC Capital has kept its outperform rating on IDEX and lifted the target price to $285, reflecting confidence in the company's earnings outlook. The move comes as the stock trades near the upper end of its 52‑week range and shows a moderately strong RSI of 63.3. Analysts see the firm’s valuation as still attractive compared to peers. The update may influence how investors view IDEX’s growth prospects.
Transaction History
| AMRZ | ▲ Buy | Open Market | 3,500 | $154K | 8/25/2026 | View on chart |
| PSX | ▲ Buy | Grant | 1,423 | $200K | 1/15/2026 | View on chart |
| AMRZ | ▲ Buy | Open Market | 4,000 | $191K | 8/8/2025 | View on chart |
| TDY | ▲ Buy | Grant | 468 | $0 | 4/23/2025 | View on chart |
| PSX | ▲ Buy | Grant | 1,684 | $200K | 1/15/2025 | View on chart |
| TDY | ▲ Buy | Grant | 468 | $0 | 4/24/2024 | View on chart |
| PSX | ▲ Buy | Grant | 1,524 | $200K | 1/16/2024 | View on chart |
| TDY | ▲ Buy | Grant | 419 | $0 | 4/26/2023 | View on chart |
| PSX | ▲ Buy | Grant | 1,929 | $200K | 1/17/2023 | View on chart |
| TDY | ▲ Buy | Grant | 376 | $0 | 4/27/2022 | View on chart |
| IEX | ▲ Buy | Grant | 4,469 | $855K | 2/16/2022 | View on chart |
| IEX | ▼ Sell | Tax Withholding | 2,001 | $383K | 2/16/2022 | View on chart |
| PSX | ▲ Buy | Grant | 2,284 | $200K | 1/14/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
JP Morgan cuts Amrize price target to $48, maintains Neutral
JP Morgan has lowered its price target for Amrize to $48 while keeping a Neutral rating. This move comes as the company prepares to announce its third-quarter 2026 financial results. Recent reports also highlight the firm's regional scale and pricing power, though the current analyst target sits below the average consensus of $47.20.
JP Morgan cuts Amrize price target to $48, maintains Neutral. JP Morgan has lowered its price target for Amrize to $48 while keeping a Neutral rating. This move comes as the company prepares to announce its third-quarter 2026 financial results. Recent reports also highlight the firm's regional scale and pricing power, though the current analyst target sits below the average consensus of $47.20.